Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis

  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

The marijuana company would work with Novartis' generic drug business Sandoz, and supply non-smokable and non-combustible medical cannabis products where it is legally allowed.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 12. in CO
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

Where are your constant market updates like you provide on down days?

Cannabis King of Quebec: HEXO uplisting to NYSE soon. JV with Coors.. Better buy than Tilray hype

All I can say is L.M.F.A.O. 275-75. Yay 10% Hahahahhaahahahahhhahhah

Tilray = use extreme caution. Stock is very unstable. There's better ones out there. Just sayin.

THATs A BUY❗

When will they reach a new high?

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Cannabis company Aleafia to buy Emblem for 27% premium, in a C$173.2 million deal
Fuente: MarketWatch - 🏆 3. / 97 Leer más »

A tobacco giant hashes out a deal with a cannabis companyFaced with declining smoking rates, Altria moves into the weed business Rich Go on And switch to other medical conditions. Sorry but science is clear that cannabis is a problem as well. And then what?
Fuente: TheEconomist - 🏆 6. / 92 Leer más »

Brewer AB InBev partners with Tilray to tap cannabis drink marketAnheuser-Busch InBev , the world's largest brewer, and Canadian pot produce... 'The destination of the river is the sea! ' Meanwhile jails are still full of cannabis smokers who can't afford bail and often lose their jobs, but now there's BIG money to be made.Screw y'all!
Fuente: Reuters - 🏆 2. / 97 Leer más »